Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study

Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative S...

Full description

Saved in:
Bibliographic Details
Published inGut Vol. 54; no. 10; pp. 1377 - 1383
Main Authors Aro, P, Ronkainen, J, Talley, N J, Storskrubb, T, Bolling-Sternevald, E, Agréus, L
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and British Society of Gastroenterology 01.10.2005
BMJ Publishing Group LTD
Copyright 2005 by Gut
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. Results: The prevalence of obesity (body mass index ⩾30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). Conclusions: GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity.
AbstractList Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. Results: The prevalence of obesity (body mass index [= or >, slanted]30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). Conclusions: GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity.
We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure.BACKGROUNDWe aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure.In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation.METHODSIn a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation.The prevalence of obesity (body mass index > or =30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)).RESULTSThe prevalence of obesity (body mass index > or =30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)).GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity.CONCLUSIONSGORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity.
We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. The prevalence of obesity (body mass index > or =30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity.
Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. Results: The prevalence of obesity (body mass index ⩾30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). Conclusions: GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity.
Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this association was explained by oesophagitis or medications that lower oesophageal sphincter pressure. Methods: In a representative Swedish population, a random sample (n = 1001, mean age 53.5 years, 51% women) had upper endoscopy. GORS was defined as any bothersome heartburn or acid regurgitation. Results: The prevalence of obesity (body mass index ⩾30) was 16%; oesophagitis was significantly more prevalent in obesity (26.5%) than in normal subjects (9.3%). There were associations between obesity and GORS (odds ratio (OR) 2.05 (95% confidence interval (CI) 1.39, 3.01)), epigastric pain (OR 1.63 (95% CI 1.05, 2.55)), irritable bowel symptoms (OR 1.58 (95% CI 1.05, 2.38)), any abdominal pain (OR 1.59 (95% CI 1.08, 2.35)), vomiting (OR 3.11 (95% CI 1.18, 8.20)), retching (OR 1.74 (95% CI 1.1.3, 2.67)), diarrhoea (OR 2.2 (95% CI 1.38, 3.46)), any stool urgency (OR 1.60 (95% CI 1.04, 2.47)), nocturnal urgency (OR 2.57 (95% CI 1.33, 4.98)), and incomplete rectal evacuation (OR 1.64 (95% CI 1.09, 2.47)), adjusting for age, sex, and education. When subjects with oesophagitis and peptic ulcer were excluded, only diarrhoea, incomplete evacuation, and vomiting were significantly associated with obesity. The association between GORS and obesity remained significant adjusting for medication use (OR 1.9 (95% CI 1.3, 3.0)). Conclusions: GORS is associated with obesity; this appears to be explained by increased upper endoscopy findings in obesity.
Author Ronkainen, J
Storskrubb, T
Aro, P
Bolling-Sternevald, E
Agréus, L
Talley, N J
AuthorAffiliation 3 Astra Zeneca R&D, Mölndal, Sweden
1 Centre for Family Medicine, Karolinska Institiutet, Stockholm, Sweden
2 Center for Enteric Neurosciences Translational and Epidemiological Research (CENTER), Mayo Clinic College of Medicine, Rochester, MN, and Department of Medicine, University of Sydney and Nepean Hospital, Sydney, Australia
AuthorAffiliation_xml – name: 3 Astra Zeneca R&D, Mölndal, Sweden
– name: 2 Center for Enteric Neurosciences Translational and Epidemiological Research (CENTER), Mayo Clinic College of Medicine, Rochester, MN, and Department of Medicine, University of Sydney and Nepean Hospital, Sydney, Australia
– name: 1 Centre for Family Medicine, Karolinska Institiutet, Stockholm, Sweden
Author_xml – sequence: 1
  givenname: P
  surname: Aro
  fullname: Aro, P
  organization: Astra Zeneca R&D, Mölndal, Sweden
– sequence: 2
  givenname: J
  surname: Ronkainen
  fullname: Ronkainen, J
  organization: Astra Zeneca R&D, Mölndal, Sweden
– sequence: 3
  givenname: N J
  surname: Talley
  fullname: Talley, N J
  organization: Astra Zeneca R&D, Mölndal, Sweden
– sequence: 4
  givenname: T
  surname: Storskrubb
  fullname: Storskrubb, T
  organization: Astra Zeneca R&D, Mölndal, Sweden
– sequence: 5
  givenname: E
  surname: Bolling-Sternevald
  fullname: Bolling-Sternevald, E
  organization: Astra Zeneca R&D, Mölndal, Sweden
– sequence: 6
  givenname: L
  surname: Agréus
  fullname: Agréus, L
  organization: Astra Zeneca R&D, Mölndal, Sweden
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15917313$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:1958942$$DView record from Swedish Publication Index
BookMark eNqFks1v1DAQxS1URLeFMzcUCYkDUrZ2HMcxh0qw4ktaARIFJC6WE0-23iZ2iB3Y_e9xyFJoD3By5Pm98cubOUFH1llA6CHBS0JocbYZwzLDOF9ixnPB76AFyYsypVlZHqEFxoSnU-EYnXi_xRiXpSD30DFhgnBK6AJ1L5zeJ53yPjFWwy5RVif15eCsqZPRwq5vlbGgk43yYXDGBvDBWNUmft_1wXX-WZQkSo9tSMBq52vXR2nv-rFVwTibVMpHvQ-j3t9HdxvVenhwOE_Rp1cvL1Zv0vX7129Xz9dpxUQR0hw3jcANADABuSgyWgqR6wzzYjLOgWgsMAHKi4KQHDNdYc4b3GgGKpL0FKVzX_8D-rGS_WA6NeylU0Yerq7iF0hW4oKVkT-f-VjpQNdgw6DaG7KbFWsu5cZ9l9FMzHtq8OTQYHDfxhiR7IyvoW2VBTd6WZSMi5JOzh7fArduHGKefuolaBwKppF69LefayO_5xaBsxmoB-f9AM0fBMtpM2TcDDlthpw3IyrYLUVtwq8BxR8y7T90hyiND7C7fkYNV7LglDP57vNKri-yL-TrRy4_RP7pzFfd9r-mfgIfA9wD
CODEN GUTTAK
CitedBy_id crossref_primary_10_1111_nmo_70017
crossref_primary_10_1186_s12876_022_02531_3
crossref_primary_10_1097_MEG_0b013e328332f7b8
crossref_primary_10_1111_j_1440_1746_2011_07042_x
crossref_primary_10_1002_edm2_70041
crossref_primary_10_1108_00346650810920141
crossref_primary_10_3346_jkms_2010_25_9_1318
crossref_primary_10_1038_s41430_022_01108_3
crossref_primary_10_1111_joim_13148
crossref_primary_10_14341_omet12706
crossref_primary_10_1007_s11377_006_0059_0
crossref_primary_10_1007_s00101_011_1922_z
crossref_primary_10_1007_s42000_019_00113_9
crossref_primary_10_1016_j_cgh_2007_05_015
crossref_primary_10_1038_ijo_2010_245
crossref_primary_10_1113_EP085427
crossref_primary_10_1111_apt_15500
crossref_primary_10_1185_03007990903080931
crossref_primary_10_1177_1756283X14538689
crossref_primary_10_1007_s11695_008_9462_6
crossref_primary_10_3389_fped_2023_1241801
crossref_primary_10_1053_j_gastro_2007_01_047
crossref_primary_10_1038_s41430_018_0109_y
crossref_primary_10_1586_17474124_2_1_93
crossref_primary_10_14309_ajg_0000000000002400
crossref_primary_10_4166_kjg_2012_59_1_1
crossref_primary_10_1097_MEG_0b013e3282f246a2
crossref_primary_10_1016_j_ejphar_2024_176881
crossref_primary_10_14309_00000434_200612001_00009
crossref_primary_10_1016_j_gtc_2009_12_007
crossref_primary_10_1111_nmo_13549
crossref_primary_10_1111_obr_13673
crossref_primary_10_3390_nu14194157
crossref_primary_10_26442_00403660_2021_08_200983
crossref_primary_10_1038_s41598_022_23098_9
crossref_primary_10_1016_j_nut_2019_02_004
crossref_primary_10_1186_s12937_019_0487_6
crossref_primary_10_1016_j_gcb_2008_12_008
crossref_primary_10_5056_jnm14124
crossref_primary_10_1038_s41575_021_00487_5
crossref_primary_10_1016_j_gastrohep_2016_08_001
crossref_primary_10_1007_s10620_008_0411_y
crossref_primary_10_4103_ejim_ejim_42_17
crossref_primary_10_3746_pnf_2021_26_2_146
crossref_primary_10_1016_j_obpill_2023_100055
crossref_primary_10_1111_j_1467_789X_2011_00969_x
crossref_primary_10_1186_s40608_018_0206_4
crossref_primary_10_1111_j_1572_0241_2006_01015_x
crossref_primary_10_1016_S0739_5930_08_70264_2
crossref_primary_10_1007_s11695_024_07080_0
crossref_primary_10_1016_j_ajcnut_2025_03_001
crossref_primary_10_1111_j_1365_2036_2009_04021_x
crossref_primary_10_1039_D3EN00650F
crossref_primary_10_1186_s12944_025_02451_7
crossref_primary_10_1002_jgh3_12757
crossref_primary_10_26442_20751753_2022_5_201730
crossref_primary_10_1590_S0004_28032009000100008
crossref_primary_10_4082_kjfm_2010_31_1_44
crossref_primary_10_5056_jnm_2010_16_3_291
crossref_primary_10_1002_ueg2_12334
crossref_primary_10_1097_01_mcg_0000225631_07039_6d
crossref_primary_10_1053_j_gastro_2016_12_052
crossref_primary_10_1016_j_amjmed_2012_08_017
crossref_primary_10_1016_j_gastre_2017_05_005
crossref_primary_10_1038_s41598_024_66869_2
crossref_primary_10_1186_s12889_023_16543_5
crossref_primary_10_1007_s11605_007_0294_9
crossref_primary_10_1111_j_1572_0241_2007_01342_x
crossref_primary_10_3748_wjg_v23_i26_4689
crossref_primary_10_1016_j_orcp_2015_05_018
crossref_primary_10_17116_dokgastro20211002152
crossref_primary_10_5056_jnm_2010_16_1_8
crossref_primary_10_1097_MEG_0b013e32832a7d87
crossref_primary_10_4254_wjh_v13_i12_1816
crossref_primary_10_1007_s00535_015_1111_y
crossref_primary_10_1016_j_cgh_2014_03_021
crossref_primary_10_1053_j_gastro_2006_02_048
crossref_primary_10_1097_MCG_0000000000000364
crossref_primary_10_1016_j_gastha_2022_07_019
crossref_primary_10_1007_s11695_016_2100_9
crossref_primary_10_1016_j_diabet_2015_11_006
crossref_primary_10_1097_CM9_0000000000002147
crossref_primary_10_1185_030079906X89748
crossref_primary_10_1371_journal_pone_0123993
crossref_primary_10_3390_biomedicines12081854
crossref_primary_10_3904_kjm_2019_94_5_425
crossref_primary_10_3164_jcbn_22_143
crossref_primary_10_1016_j_soard_2014_09_004
crossref_primary_10_1002_ibd_21801
crossref_primary_10_1111_jgh_13146
crossref_primary_10_1186_s12876_017_0650_5
ContentType Journal Article
Copyright Copyright 2005 by Gut
Copyright: 2005 Copyright 2005 by Gut
Copyright © Copyright 2005 by Gut 2005
Copyright_xml – notice: Copyright 2005 by Gut
– notice: Copyright: 2005 Copyright 2005 by Gut
– notice: Copyright © Copyright 2005 by Gut 2005
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
88I
8AF
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
ADTPV
AOWAS
DOI 10.1136/gut.2004.057497
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
BMJ Journals
ProQuest One Community College
ProQuest Central Korea
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
MEDLINE - Academic
MEDLINE



Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-3288
1458-3288
EndPage 1383
ExternalDocumentID oai_swepub_ki_se_580658
PMC1774688
4014125611
15917313
10_1136_gut_2004_057497
ark_67375_NVC_LT2W1ZS7_P
gutjnl
Genre Journal Article
GeographicLocations Sweden
United States--US
GeographicLocations_xml – name: Sweden
– name: United States--US
GroupedDBID ---
.55
.GJ
.VT
08G
0R~
18M
29I
2WC
354
39C
3O-
4.4
40O
53G
5GY
5VS
7X7
7~S
88E
88I
8AF
8F7
8FE
8FH
8FI
8FJ
8R4
8R5
AAHLL
AAKAS
AAOJX
AAUVZ
AAWJN
AAYEP
ABAAH
ABKDF
ABMQD
ABOCM
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACOAB
ACOFX
ACQSR
ACTZY
ADBBV
ADCEG
ADFRT
ADUGQ
ADZCM
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AI.
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C1A
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DU5
DWQXO
E3Z
EBS
EJD
F5P
FD8
FEDTE
FYUFA
GNUQQ
GX1
H13
HAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IH2
IHR
INH
INR
IOF
ITC
J5H
KQ8
L7B
LK8
M1P
M2P
M7P
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
TEORI
TR2
UKHRP
UYXKK
V24
VH1
VM9
VVN
W8F
WH7
WOQ
X7M
YFH
YOC
YQY
ZGI
ZXP
ZY1
3V.
ABJNI
BSCLL
RHF
AAYXX
ACQHZ
ADGHP
AERUA
CITATION
PHGZM
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ADTPV
AOWAS
PUEGO
ID FETCH-LOGICAL-b596t-40ff90feee59e496238994d207659177e1d0901e376611405db077f0fd5ea9943
IEDL.DBID 7X7
ISSN 0017-5749
IngestDate Mon Aug 25 03:40:48 EDT 2025
Thu Aug 21 13:49:41 EDT 2025
Fri Jul 11 05:07:08 EDT 2025
Fri Jul 25 11:10:42 EDT 2025
Wed Feb 19 01:40:23 EST 2025
Thu Apr 24 22:57:54 EDT 2025
Tue Jul 01 04:11:14 EDT 2025
Wed Oct 30 09:39:13 EDT 2024
Thu Apr 24 23:05:35 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b596t-40ff90feee59e496238994d207659177e1d0901e376611405db077f0fd5ea9943
Notes istex:220CF6A2CC4FC4BA1F27B94F4CBEE5EDD056A882
href:gutjnl-54-1377.pdf
PMID:15917313
Correspondence to:
 Professor N J Talley
 Mayo Clinic College of Medicine, Center for Enteric Neurosciences Translational and Epidemiological Research (CENTER), Mayo Clinic, 200 First St, PL-6-56, Rochester, MN 55905, USA; talley.nicholas@mayo.edu
ark:/67375/NVC-LT2W1ZS7-P
local:0541377
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Correspondence to: …Professor N J Talley …Mayo Clinic College of Medicine, Center for Enteric Neurosciences Translational and Epidemiological Research (CENTER), Mayo Clinic, 200 First St, PL-6-56, Rochester, MN 55905, USA; talley.nicholas@mayo.edu
Published online first 25 May 2005
OpenAccessLink https://gut.bmj.com/content/gutjnl/54/10/1377.full.pdf
PMID 15917313
PQID 1779331303
PQPubID 2041069
PageCount 7
ParticipantIDs swepub_primary_oai_swepub_ki_se_580658
pubmedcentral_primary_oai_pubmedcentral_nih_gov_1774688
proquest_miscellaneous_68579834
proquest_journals_1779331303
pubmed_primary_15917313
crossref_primary_10_1136_gut_2004_057497
crossref_citationtrail_10_1136_gut_2004_057497
istex_primary_ark_67375_NVC_LT2W1ZS7_P
bmj_primary_10_1136_gut_2004_057497
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2005-10-01
PublicationDateYYYYMMDD 2005-10-01
PublicationDate_xml – month: 10
  year: 2005
  text: 2005-10-01
  day: 01
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Gut
PublicationTitleAlternate Gut
PublicationYear 2005
Publisher BMJ Publishing Group Ltd and British Society of Gastroenterology
BMJ Publishing Group LTD
Copyright 2005 by Gut
Publisher_xml – name: BMJ Publishing Group Ltd and British Society of Gastroenterology
– name: BMJ Publishing Group LTD
– name: Copyright 2005 by Gut
References 8122651 - Am J Gastroenterol. 1994 Mar;89(3):387-91
6288509 - Gastroenterology. 1982 Nov;83(5):963-9
15339321 - Aliment Pharmacol Ther. 2004 Sep 1;20(5):497-505
10548135 - J Clin Psychiatry. 1999;60 Suppl 21:5-9
14687160 - Am J Gastroenterol. 2004 Jan;99(1):170-81
3237852 - Physiol Behav. 1988;44(4-5):665-8
15012771 - J Gastroenterol Hepatol. 2004 Apr;19(4):357-67
15051594 - Am J Clin Nutr. 2004 Apr;79(4):537-43
15305996 - Neurogastroenterol Motil. 2004 Aug;16(4):413-9
984016 - Am J Dig Dis. 1976 Nov;21(11):953-6
8389339 - Int J Obes Relat Metab Disord. 1993 May;17(5):295-300
15181019 - J Clin Endocrinol Metab. 2004 Jun;89(6):2522-5
12837713 - JAMA. 2003 Jul 2;290(1):66-72
10861260 - Gut. 2000 Jul;47(1):26-9
9136821 - Gastroenterology. 1997 May;112(5):1448-56
8146509 - Scand J Prim Health Care. 1993 Dec;11(4):252-62
10906830 - Ann Intern Med. 2000 Aug 1;133(3):165-75
1967675 - Lancet. 1990 Jan 27;335(8683):205-8
10378622 - Am J Med. 1999 Jun;106(6):642-9
10720111 - Scand J Gastroenterol. 2000 Feb;35(2):142-51
9659166 - Gut. 1998 May;42(5):690-5
12913045 - Int J Epidemiol. 2003 Aug;32(4):645-50
9829354 - Scand J Gastroenterol. 1998 Oct;33(10):1023-9
12126237 - Scand J Gastroenterol. 2002 Jun;37(6):626-30
3414573 - Am J Clin Nutr. 1988 Sep;48(3):592-4
7657095 - Gastroenterology. 1995 Sep;109(3):671-80
12181383 - Obes Res. 2002 Aug;10(8):748-56
7395839 - Am J Gastroenterol. 1980 Feb;73(2):127-30
15089906 - Am J Gastroenterol. 2004 Apr;99(4):711-8
10638576 - Am J Gastroenterol. 2000 Jan;95(1):157-65
15330923 - Am J Gastroenterol. 2004 Sep;99(9):1807-14
2338264 - Gut. 1990 Apr;31(4):401-5
12365955 - JAMA. 2002 Oct 9;288(14):1723-7
15229334 - Obes Res. 2004 Jun;12(6):949-55
15330922 - Am J Gastroenterol. 2004 Sep;99(9):1801-6
663647 - Science. 1978 Jul 14;201(4351):165-7
11693325 - Am J Gastroenterol. 2001 Oct;96(10):2905-14
15104363 - Dig Dis Sci. 2004 Feb;49(2):237-42
8793471 - Eur Respir J. 1996 May;9(5):1073-8
15113714 - Am J Clin Nutr. 2004 May;79(5):774-9
15743007 - Scand J Gastroenterol. 2004 Dec;39(12):1280-8
1804576 - Dig Dis. 1991;9(6):360-4
3116071 - J Clin Gastroenterol. 1987 Aug;9(4):386-9
15932168 - Scand J Gastroenterol. 2005 Mar;40(3):275-85
10501410 - Ann Epidemiol. 1999 Oct;9(7):424-35
14647184 - Int J Obes Relat Metab Disord. 2004 Feb;28(2):254-61
15199035 - JAMA. 2004 Jun 16;291(23):2847-50
7714465 - J Intern Med. 1995 Apr;237(4):411-8
15086867 - Neurogastroenterol Motil. 2004 Apr;16(2):135-42
References_xml – reference: 15089906 - Am J Gastroenterol. 2004 Apr;99(4):711-8
– reference: 10378622 - Am J Med. 1999 Jun;106(6):642-9
– reference: 14687160 - Am J Gastroenterol. 2004 Jan;99(1):170-81
– reference: 15199035 - JAMA. 2004 Jun 16;291(23):2847-50
– reference: 12181383 - Obes Res. 2002 Aug;10(8):748-56
– reference: 15104363 - Dig Dis Sci. 2004 Feb;49(2):237-42
– reference: 7714465 - J Intern Med. 1995 Apr;237(4):411-8
– reference: 3237852 - Physiol Behav. 1988;44(4-5):665-8
– reference: 3414573 - Am J Clin Nutr. 1988 Sep;48(3):592-4
– reference: 14647184 - Int J Obes Relat Metab Disord. 2004 Feb;28(2):254-61
– reference: 2338264 - Gut. 1990 Apr;31(4):401-5
– reference: 15051594 - Am J Clin Nutr. 2004 Apr;79(4):537-43
– reference: 15743007 - Scand J Gastroenterol. 2004 Dec;39(12):1280-8
– reference: 8146509 - Scand J Prim Health Care. 1993 Dec;11(4):252-62
– reference: 15012771 - J Gastroenterol Hepatol. 2004 Apr;19(4):357-67
– reference: 8389339 - Int J Obes Relat Metab Disord. 1993 May;17(5):295-300
– reference: 12365955 - JAMA. 2002 Oct 9;288(14):1723-7
– reference: 7657095 - Gastroenterology. 1995 Sep;109(3):671-80
– reference: 9136821 - Gastroenterology. 1997 May;112(5):1448-56
– reference: 15229334 - Obes Res. 2004 Jun;12(6):949-55
– reference: 984016 - Am J Dig Dis. 1976 Nov;21(11):953-6
– reference: 6288509 - Gastroenterology. 1982 Nov;83(5):963-9
– reference: 9659166 - Gut. 1998 May;42(5):690-5
– reference: 8793471 - Eur Respir J. 1996 May;9(5):1073-8
– reference: 10501410 - Ann Epidemiol. 1999 Oct;9(7):424-35
– reference: 9829354 - Scand J Gastroenterol. 1998 Oct;33(10):1023-9
– reference: 7395839 - Am J Gastroenterol. 1980 Feb;73(2):127-30
– reference: 10906830 - Ann Intern Med. 2000 Aug 1;133(3):165-75
– reference: 10638576 - Am J Gastroenterol. 2000 Jan;95(1):157-65
– reference: 12126237 - Scand J Gastroenterol. 2002 Jun;37(6):626-30
– reference: 663647 - Science. 1978 Jul 14;201(4351):165-7
– reference: 15330922 - Am J Gastroenterol. 2004 Sep;99(9):1801-6
– reference: 11693325 - Am J Gastroenterol. 2001 Oct;96(10):2905-14
– reference: 8122651 - Am J Gastroenterol. 1994 Mar;89(3):387-91
– reference: 15339321 - Aliment Pharmacol Ther. 2004 Sep 1;20(5):497-505
– reference: 1804576 - Dig Dis. 1991;9(6):360-4
– reference: 12837713 - JAMA. 2003 Jul 2;290(1):66-72
– reference: 15113714 - Am J Clin Nutr. 2004 May;79(5):774-9
– reference: 15181019 - J Clin Endocrinol Metab. 2004 Jun;89(6):2522-5
– reference: 15086867 - Neurogastroenterol Motil. 2004 Apr;16(2):135-42
– reference: 10861260 - Gut. 2000 Jul;47(1):26-9
– reference: 15330923 - Am J Gastroenterol. 2004 Sep;99(9):1807-14
– reference: 15932168 - Scand J Gastroenterol. 2005 Mar;40(3):275-85
– reference: 1967675 - Lancet. 1990 Jan 27;335(8683):205-8
– reference: 15305996 - Neurogastroenterol Motil. 2004 Aug;16(4):413-9
– reference: 10548135 - J Clin Psychiatry. 1999;60 Suppl 21:5-9
– reference: 3116071 - J Clin Gastroenterol. 1987 Aug;9(4):386-9
– reference: 12913045 - Int J Epidemiol. 2003 Aug;32(4):645-50
– reference: 10720111 - Scand J Gastroenterol. 2000 Feb;35(2):142-51
SSID ssj0008891
Score 2.16079
Snippet Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to...
We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to determine if this...
Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to...
SourceID swepub
pubmedcentral
proquest
pubmed
crossref
istex
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1377
SubjectTerms Abdomen
abdominal symptom questionnaire
Antacids - therapeutic use
ASQ
BMI
Body Mass Index
Chronic Disease
Cohort Studies
dyspepsia
Endoscopy, Gastrointestinal - methods
epidemiology
Esophageal Sphincter, Lower - drug effects
Esophageal Sphincter, Lower - physiopathology
Esophagitis - complications
Esophagitis - epidemiology
Female
gastro-oesophageal reflux disease
gastro-oesophageal reflux symptoms
Gastroesophageal reflux
Gastroesophageal Reflux - epidemiology
Gastroesophageal Reflux - etiology
Gastroesophageal Reflux - physiopathology
gastrointestinal symptoms
GORD
GORS
Humans
IBS
identity number
irritable bowel syndrome
LOS
lower oesophageal sphincter
Male
Middle Aged
obesity
Obesity - complications
Obesity - epidemiology
Obesity - physiopathology
odds ratio
OEG
oesophagogastroduodenoscopy
population study
Population Surveillance - methods
Population-based studies
Pressure
Prevalence
questionnaires
Sweden - epidemiology
Title Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study
URI http://gut.bmj.com/content/54/10/1377.full
https://api.istex.fr/ark:/67375/NVC-LT2W1ZS7-P/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/15917313
https://www.proquest.com/docview/1779331303
https://www.proquest.com/docview/68579834
https://pubmed.ncbi.nlm.nih.gov/PMC1774688
http://kipublications.ki.se/Default.aspx?queryparsed=id:1958942
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Zb9QwELagKyFeEDeBUiyBEC9pk40dO7wgWlqVo6sKWljxYiVru0Cbg01Wav89M85RRVxvSexxLM94jnjyDSHPUsaTFPjuc2mlz6zRvgQz4GvJsHyctpnG_50PZvH-MXs35_Pug1vdpVX2OtEpal0u8Bv5VihgxAg17qvqp49Vo_B0tSuhcZVMELoMU7rEfAi4MIMn7DUxFyzpoH3CKN46WblESrYZYAPapiz_MbJNE1zm8z85nr_nT45QRp1l2rtJbnQuJX3dysAtcsUUt8m1g-7Q_A7Jt0t9QXPwkqnDRqRpoemiBcWlq8KcV2cpdNT0JK2bZYkAErDvccj6Iq-aMq9fAgl1SB3UFLrEP1mAtBpqf1G0hZo6qNq75Hhv92hn3--qLPgZT-IGAkhrk8AaY3hiWALuEIRgTE8DEXOI5YQJdQBOgwFNFEPwFHCdBULYwGpuUugZ3SNrRVmYB4QyE5lY2qk1VsNIMuNTk2VWJwtroshyjzyFVVZVi6OhXPwRxQp4gdUwmWp54ZHNngtq0QGVY72Ms78TvBgI_jv2c8fWoV-6PMXUNsHV7POO-nA0_RJ-_STUoUfWe76rblfX6lIGPfJkaIb9iIcsaWHKVa1iyUUiI-aR-62QXE4JlxOoPSJG4jN0QKTvcUvx_ZtD_IYXs1hKmH0raCOS7tEpXBnF8aBcPvz37B-R6z0CbRCuk7VmuTKPwbdqsg23gTbIZHt3dvgR7t68ff8L7iAmVw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NVgJeEN8LDGaJD_GSLU3sxEFCiI1NHWurCTqYePGS2h6wNQlNK9Z_ir-Rc76miK-nvUW172Lld77z1fbvAJ5GlIUR4m4zrrlNtZI2xzBgS05N-TipY2nuOw9Hfv-QvjtiRyvws74LY45V1j6xcNQynZj_yDd7AWr0jMd9nX23TdUos7tal9AozWJfLX9gypa_2nuL-D5z3d2d8XbfrqoK2DEL_TkmTFqHjlZKsVDREMM_phxUupjQM8xdAtWTDgZJhTPPx2TBYTJ2gkA7WjIVYU8P9V6BLvUwlelAd2tndPC-8f28rtGHvp8FNKzIhHqev3myKI5u0g3HNJhoGE-_taJh1wB7_qel7u8nNlu8pkUs3L0JN6pFLHlTWt0tWFHJbbg6rLbp78B0K5VLMsV1OSnYGEmUSDIpaXjJIlHn2VmEHSU5ifL5LDWUFehpjMp8Oc3m6TR_iSKk4AYhKpGpuTuDollTbYyY6CtJQY57Fw4vBYF70EnSRK0CocpTPteuVlqiJh4zV8WxluFEK8_TzIIn-JVFVjJ3iCLj8XyBWJj6m1SUWFiwUaMgJhU1uqnQcfZ3gReNwH91Py9gbfpFs1NzmC5gYvRxWwzG7qfe5w-BOLBgrcZdVH4kFxdWb8F604wewGzrRIlKF7nwOQtC7lEL7pdGcjEk8zlR2oKgZT5NB8Mt3m5Jvn4pOMbxxdTnHEdfGlpLpPrpFJ-UYGZrnj_49-jX4Vp_PByIwd5o_yFcr_lvnd4adOazhXqEK7t5_LiaTgSOL3sG_wIHV1_Z
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZbxMxELZKK1W8IG4WCrXEIV622cNee5EQgpaopW1UiRYiXsxubLelze6STUTz1_h1zOxVRVxPfYtiz8TyXJ54_A0hzxLG4wTk7nJppcus0a6EMOBqybB9nLapxvfO-4No-4h9GPLhEvnZvoXBssrWJ1aOWucj_I-85wvgGKLH7dmmLOJgq_-m-O5iBym8aW3badQqsmvmPyB9K1_vbIGsnwdB__3h5rbbdBhwUx5HU0ierI09a4zhsWExHAUg_WA6gOSeQx4jjK89CJgGrDCCxMHjOvWEsJ7V3CQwMwS-18iKCLmPNiaGXbKH1UN-GwW4YHEDK-SHUe94VhVxsg0PBzAupuNvC3FxBUV88adD7--1mwsIp1VU7N8kN5rjLH1b698tsmSy22R1v7mwv0PG73I9p2M4odMKl5EmmaajGpCXzjJzUZwnMFHT46ScTnIErwCfgyzL-biY5uPyFZDQCiWEmkzn-IoGSIuu7xjFOKxpBZN7lxxdyf7fI8tZnpkHhDITmkjawBqrgZNMeWDS1Op4ZE0YWu6Qp7DLqqgxPFSV-4SRAllgJ06malk4ZKOVgho1IOnYq-P87wQvO4L_8n5RibWbl0zOsKxOcDX4tKn2DoPP_pePQh04ZK2Vu2o8Sqku9d8h690w-AK84Ekyk89KFUkuYhkyh9yvleRySbidQO0QsaA-3QREGV8cyU5PKrRx-GEWSQmrrxVtgaT56gw-GcXxkl4-_Pfq18kq2K3a2xnsPiLXWyBcz18jy9PJzDyGI940fVLZEiVfr9p4fwGDBWKp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Body+mass+index+and+chronic+unexplained+gastrointestinal+symptoms%3A+an+adult+endoscopic+population+based+study&rft.jtitle=Gut&rft.au=Aro%2C+P&rft.au=Ronkainen%2C+J&rft.au=Talley%2C+N+J&rft.au=Storskrubb%2C+T&rft.date=2005-10-01&rft.issn=0017-5749&rft.volume=54&rft.issue=10&rft.spage=1377&rft_id=info:doi/10.1136%2Fgut.2004.057497&rft_id=info%3Apmid%2F15917313&rft.externalDocID=15917313
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0017-5749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0017-5749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0017-5749&client=summon